Literature DB >> 17875067

A teaching hospital's experience applying the Pneumonia Severity Index and antibiotic guidelines in the management of community-acquired pneumonia.

Richard Wai Wing Lee1, Steven Terence Lindstrom.   

Abstract

BACKGROUND AND OBJECTIVES: The Pneumonia Severity Index (PSI) was developed to predict mortality in community-acquired pneumonia (CAP). It has been prospectively validated to identify patients who are at low risk of death and thereby aid in the selection of patients for outpatient management. This study assessed the compliance of medical staff at a university teaching hospital with the use of the PSI and the PSI-based local antibiotic guidelines in admitted patients.
METHODS: This was a retrospective study of 137 consecutive adults admitted with a primary diagnosis of CAP between July and December 2003. Implementation of the PSI and local antibiotic guidelines occurred 4 months prior to the study period. The data collected included patient demographics, PSI parameters, patient outcomes, adherence and compliance with the PSI scoring process and local antibiotic guidelines.
RESULTS: Forty per cent of all CAP admissions were patients in PSI Class I to III. The compliance with scoring the PSI was low (45 out of 137 patients; 33%), as was the accuracy of the PSI scoring (26 out of 45 patients; 58%). Compliance with the local antibiotic guidelines was 87% in patients in whom the PSI was performed.
CONCLUSIONS: In admitted patients, non-adherence with the PSI admission guidelines was common. Compliance with scoring the PSI and its scoring accuracy was low. This may be due to a lack of awareness and its relative complexity. Further studies to identify potential barriers to compliance are warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17875067     DOI: 10.1111/j.1440-1843.2007.01121.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  17 in total

1.  CURB-65 pneumonia severity assessment adapted for electronic decision support.

Authors:  Barbara E Jones; Jason Jones; Thomas Bewick; Wei Shen Lim; Dominik Aronsky; Samuel M Brown; Wim G Boersma; Menno M van der Eerden; Nathan C Dean
Journal:  Chest       Date:  2010-12-16       Impact factor: 9.410

2.  Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey.

Authors:  P Schuetz; M Batschwaroff; F Dusemund; W Albrich; U Bürgi; M Maurer; M Brutsche; A R Huber; B Müller
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-29       Impact factor: 3.267

3.  Hospital admission decision for patients with community-acquired pneumonia.

Authors:  Stefano Aliberti; Paola Faverio; Francesco Blasi
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

4.  Role of Semi-quantitative Serum Procalcitonin in Assessing Prognosis of Community Acquired Bacterial Pneumonia Compared to PORT PSI, CURB-65 and CRB-65.

Authors:  Lalita Fernandes; Akashdeep Singh Arora; Anthony Menezes Mesquita
Journal:  J Clin Diagn Res       Date:  2015-07-01

5.  Hospital admission decision for patients with community-acquired pneumonia: variability among physicians in an emergency department.

Authors:  Nathan C Dean; Jason P Jones; Dominik Aronsky; Samuel Brown; Caroline G Vines; Barbara E Jones; Todd Allen
Journal:  Ann Emerg Med       Date:  2011-09-09       Impact factor: 5.721

6.  Predicting Severe Pneumonia Outcomes in Children.

Authors:  Derek J Williams; Yuwei Zhu; Carlos G Grijalva; Wesley H Self; Frank E Harrell; Carrie Reed; Chris Stockmann; Sandra R Arnold; Krow K Ampofo; Evan J Anderson; Anna M Bramley; Richard G Wunderink; Jonathan A McCullers; Andrew T Pavia; Seema Jain; Kathryn M Edwards
Journal:  Pediatrics       Date:  2016-10       Impact factor: 7.124

7.  Clinical predictors for Legionella in patients presenting with community-acquired pneumonia to the emergency department.

Authors:  Rico Fiumefreddo; Roya Zaborsky; Jeannine Haeuptle; Mirjam Christ-Crain; Andrej Trampuz; Ingrid Steffen; Reno Frei; Beat Müller; Philipp Schuetz
Journal:  BMC Pulm Med       Date:  2009-01-19       Impact factor: 3.317

8.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

9.  Prohormones for prediction of adverse medical outcome in community-acquired pneumonia and lower respiratory tract infections.

Authors:  Philipp Schuetz; Marcel Wolbers; Mirjam Christ-Crain; Robert Thomann; Claudine Falconnier; Isabelle Widmer; Stefanie Neidert; Thomas Fricker; Claudine Blum; Ursula Schild; Nils G Morgenthaler; Ronald Schoenenberger; Christoph Henzen; Thomas Bregenzer; Claus Hoess; Martin Krause; Heiner C Bucher; Werner Zimmerli; Beat Mueller
Journal:  Crit Care       Date:  2010-06-08       Impact factor: 9.097

10.  Efficacy of Omadacycline Versus Moxifloxacin in the Treatment of Community-Acquired Bacterial Pneumonia by Disease Severity: Results From the OPTIC Study.

Authors:  Julio Ramirez; Daniel H Deck; Paul B Eckburg; Marla Curran; Anita F Das; Courtney Kirsch; Amy Manley; Evan Tzanis; Paul C McGovern
Journal:  Open Forum Infect Dis       Date:  2021-06-18       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.